. home.aspx

NEWS

home.aspx
   


Astellas and LEO Pharma Close Transaction to Transfer Global Dermatology Business

April 01, 2016 / Astellas
SHARESHARESHARE

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and LEO Pharma A/S (President and CEO: Gitte P. Aabo, “LEO Pharma”) today announced that the two companies completed the relevant closing conditions on March 31, 2016 to allow the transfer of the Astellas’ global dermatology business to LEO Pharma from 0 a.m. on April 1.